ClinicalTrials.gg
CompletedNCT02319096Updated Oct 17, 2016

Vibration Training and Pelvic Floor Muscle Strength in Females With Stress Urinary Incontinence

An interventional study of Whole body vibration therapy in Urinary Stress Incontinence, sponsored by Medway NHS Foundation Trust. Completed at 1 site in United Kingdom. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-10-17.

Sponsored by Medway NHS Foundation Trust · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Urinary Incontinence, Stress with a site in United Kingdom — 3 open to participants now, 5 under way, 1 of them phase 3. Urinary Incontinence, Stress · United Kingdom.

Enrollment
20th of 21
10 · median 123
Started
2014
the only one that year
No phase
10 of 28
2 open now
Registered
15th of 28
by date
Lead sponsor
2 of 28
Medway NHS Foundation Trust

Among the 28 studies in Urinary Incontinence, Stress with a site in United Kingdom, this one is the 20th largest by enrollment of the 21 interventional ones that give a count, is the only one that started in 2014, is one of 10 with no phase, and was the 15th registered.

Urinary Incontinence, Stress

655 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

3 of the 28 studies in Urinary Incontinence, Stress with a site in United Kingdom are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 76 Urinary Incontinence, Stress studies recruiting now, 43 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Urinary Incontinence, Stress with a site in United Kingdom, or all of them as a file.
02

Study summary

Pelvic floor muscle training (PFMT) is the first line therapy recommended by NICE for the treatment of SUI. Due to poor motivation and compliance only 15-20% of women comply with the regimen. Whole body vibration (WBV) exercise has been developed as a new modality in the field of physiotherapy. The Galileo machine is a unique device for applying whole-body vibration. The investigators are currently using this therapy as an alternative to traditional pelvic floor muscle therapy. The investigators aim to audit the investigators treatment of whole body vibration.

Read the detailed description

Pelvic floor muscle training (PFMT) is the first line therapy recommended by NICE for the treatment of SUI. It was first described by Arnold Kegel almost 60 years ago. PFMT exercises help the patient strengthen the muscles of the pelvic floor by the repeated high-intensity, rapid pelvic muscle contractions of both slow and fast twitch muscle fibres. The training of these muscles is difficult particularly when women have trouble in the perception of their PFM. This results in poor motivation and compliance with a Cochrane review suggesting that only 15-20% of women comply with the regimen.

Whole body vibration (WBV) exercise has been developed as a new modality in the field of physiotherapy. Whole body vibration (WBW) has a positive effect on muscle strength and rate of force. Stochastic WBV causes up to 12 muscle contractions per second which cannot be achieved by routine PFM exercise with supervision of a physiotherapist. The Galileo machine is a unique device for applying whole-body vibration. The investigators aim to audit their treatment of whole body vibration. This would be done using the patient global impression of improvement scale (PGI-I) and routine quality of life and symptoms questionnaires (International Consultation on Incontinence Female lower Urinary Tract Symptoms Questionnaire -ICIQ-FLUTS and Pelvic Floor Distress Inventory - PFDI) to be completed by the patient at initial appointment and 12 weeks after treatment and pelvic floor muscle assessment carried out at initial appointment and at 12 weeks. Patients will also have a qualitative interview with the Urogynaecology team to assess if therapy was found to be suitable and acceptable to patients.

03

Conditions studied

  • Urinary Stress Incontinence

Keywords

  • Whole body vibration therapy
  • pelvic floor muscle training
  • stress urinary incontinence
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Stress predominant urinary incontinence
  2. Female patients >18 years

Exclusion criteria

Exclusion Criteria:

  1. Urgency predominant urinary incontinence
  2. Symptomatic pelvic organ prolapse requiring intervention
  3. Patients with bladder pathology (eg haematuria of unknown origin, UTI)
  4. to Whole Body Vibration

    • Musculoskeletal

      • Hip or knee endoprosthesis
      • Acute disc herniation
      • Joint fusion with metal implants
      • Acute arthritis
      • Osteoporosis with vertebral fracture
      • Recent Fracture
      • Acute Soft Tissue Injury
      • Acute Rheumatoid Arthritis
    • Cardiovascular

      • Recent myocardial infarction
      • Hypertension
      • Serious cardiovascular disease
      • Artificial heart valves
      • Pacemaker
      • Venous Thrombosis
      • Aortic Aneurysm
      • Peripheral vascular disease
      • Untreated orthostatic hypotension
      • Hernia
    • Neuromuscular

      • Impaired sensation
      • Impaired cognition
      • Deep brain and spinal cord stimulators
    • Other

      • Malignant tumours
      • Acute oedema
      • Impaired skin integrity of foot or leg
      • Recent surgery
      • Severe diabetes or migraines
      • Kidney and bladder stones
      • Pregnancy
      • Recently placed intrauterine devices or pins
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Patients with stress incontinence

    Patients who present to urogynaecology clinic with proven stress urinary incontinence who will be offered Whole body vibration therapy.

    Other: Whole body vibration therapy

Interventions

  • OtherWhole body vibration therapy

    Whole body vibration therapy using the Galileo machine as therapy for pelvic floor muscle training

06

What researchers measure

Primary outcomes

  1. Patient Global Impression of Improvement scale (PGI-I)

    Patients will be asked answer the PGI-I questionnaire after a full 12 week course of therapy

    Time frame: 12 weeks

Secondary outcomes

  1. International Consultation on Incontinence Female lower Urinary Tract Symptoms Questionnaire

    Patients will be asked to answer the ICIQ-FLUTS to assess symptom improvement after a full 12 week course of therapy

    Time frame: 12 weeks

  2. Pelvic Floor Distress Inventory - PFDI

    Patients will be asked to answer the PFDI-I to assess any improvement in quality of life after a full 12 weeks

    Time frame: 12 weeks

  3. Qualitative interview

    A qualitative interview will be conducted with the urogynaecology team to assess if patients found the new therapy suitable and acceptable.

    Time frame: 12 weeks

  4. Pelvic muscle contraction

    Pelvic muscle contraction will be measured at Week 0 and Week 12 using a pelvic perineometer to assess any improvement in pelvic muscle strength

    Time frame: 12 weeks

07

Study locations

1 site
  • Medway Maritime Hospital
    Gillingham, Kent Me7 5NY, United Kingdom
08

References and documents

Publications

  • Goode PS, Burgio KL, Locher JL, Roth DL, Umlauf MG, Richter HE, Varner RE, Lloyd LK. Effect of behavioral training with or without pelvic floor electrical stimulation on stress incontinence in women: a randomized controlled trial. JAMA. 2003 Jul 16;290(3):345-52. doi: 10.1001/jama.290.3.345. PubMed 12865375 ↗
  • Rovner ES, Wein AJ. Treatment options for stress urinary incontinence. Rev Urol. 2004;6 Suppl 3(Suppl 3):S29-47. PubMed 16985862 ↗
  • Luginbuehl H, Lehmann C, Gerber R, Kuhn A, Hilfiker R, Baeyens JP, Radlinger L. Continuous versus intermittent stochastic resonance whole body vibration and its effect on pelvic floor muscle activity. Neurourol Urodyn. 2012 Jun;31(5):683-7. doi: 10.1002/nau.21251. Epub 2012 Mar 6. PubMed 22395850 ↗
  • Kawanabe K, Kawashima A, Sashimoto I, Takeda T, Sato Y, Iwamoto J. Effect of whole-body vibration exercise and muscle strengthening, balance, and walking exercises on walking ability in the elderly. Keio J Med. 2007 Mar;56(1):28-33. doi: 10.2302/kjm.56.28. PubMed 17392595 ↗
  • Vella M, Nellist E, Cardozo L, Mastoroudes H, Giarenis I, Duckett J. Does self-motivation improve success rates of pelvic floor muscle training in women with urinary incontinence in a secondary care setting? Int Urogynecol J. 2013 Nov;24(11):1947-51. doi: 10.1007/s00192-013-2115-x. Epub 2013 May 24. PubMed 23702666 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2014, a primary completion of Dec 2015 and a completion of Dec 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2014
First posted
Dec 18, 2014
Start
Dec 2014
Primary completionActual
Dec 2015
CompletionActual
Dec 2015
Last update
Oct 17, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 17, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02319096
Lead sponsor
Medway NHS Foundation Trust
Responsible party
Professor Jonathan Duckett (Consultant Obstetrician and Gynaecologist, Medway NHS Foundation Trust) — Principal investigator
First posted
Dec 18, 2014
Start date
Dec 2014
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Oct 17, 2016

Study contacts

Jonathan RA Duckett, FRCOG
principal investigator · Medway Maritime Hospital NHS Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion